If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Giancarlo Pruneri is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles
Breast Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Tumor-Infiltrating Lymphocytes Medicine & Life Sciences
Survival Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences
Squamous Cell Carcinoma Medicine & Life Sciences
Breast Medicine & Life Sciences
Cyclin D1 Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1995 2019

  • 14097 Citations
  • 61 h-Index
  • 297 Article
  • 9 Review article
  • 1 Comment/debate
  • 1 Letter

Author Correction: SREBP1 drives keratin-80-dependent cytoskeletal changes and invasive behavior in endocrine-resistant ERα breast cancer (Nature Communications, (2019), 10, 1, (2115), 10.1038/s41467-019-09676-y)

Perone, Y., Farrugia, A. J., Rodríguez-Meira, A., Győrffy, B., Ion, C., Uggetti, A., Chronopoulos, A., Marrazzo, P., Faronato, M., Shousha, S., Davies, C., Steel, J. H., Patel, N., del Rio Hernandez, A., Coombes, C., Pruneri, G., Lim, A., Calvo, F. & Magnani, L., Dec 1 2019, In : Nature Communications. 10, 1, 3791.

Research output: Contribution to journalComment/debate

Open Access

Dose-adjusted EPOCH plus rituximab improves the clinical outcome of young patients affected by double expressor diffuse large B-cell lymphoma

Dodero, A., Guidetti, A., Tucci, A., Barretta, F., Novo, M., Devizzi, L., Re, A., Passi, A., Pellegrinelli, A., Pruneri, G., Miceli, R., Testi, A., Pennisi, M., Di Chio, M. C., Matteucci, P., Carniti, C., Facchetti, F., Rossi, G. & Corradini, P., Apr 1 2019, In : Leukemia. 33, 4, p. 1047-1051 5 p.

Research output: Contribution to journalLetter

Open Access

Exploiting FAsting-mimicking Diet and MEtformin to Improve the Efficacy of Platinum-pemetrexed Chemotherapy in Advanced LKB1-inactivated Lung Adenocarcinoma: The FAME Trial

Vernieri, C., Signorelli, D., Galli, G., Ganzinelli, M., Moro, M., Fabbri, A., Tamborini, E., Marabese, M., Caiola, E., Broggini, M., Hollander, L., Gallucci, R., Vandoni, G., Gavazzi, C., Triulzi, T., Colombo, M. P., Rizzo, A. M., Corsetto, P. A., Pruneri, G., de Braud, F. & 3 others, Sozzi, G., Torri, V. & Garassino, M. C., May 2019, In : Clinical Lung Cancer. 20, 3, p. e413-e417

Research output: Contribution to journalArticle


Identification of potentially druggable molecular alterations in skin adnexal malignancies

Cavalieri, S., Busico, A., Capone, I., Conca, E., Dallera, E., Quattrone, P., Licitra, L., Pruneri, G., Bossi, P. & Perrone, F., Jun 2019, In : Journal of Dermatology. 46, 6, p. 507-514 8 p.

Research output: Contribution to journalArticle

Skin Neoplasms
Androgen Receptors

Impact of systemic and tumor lipid metabolism on everolimus efficacy in advanced pancreatic neuroendocrine tumors (pNETs)

Vernieri, C., Pusceddu, S., Fucà, G., Indelicato, P., Centonze, G., Castagnoli, L., Ferrari, E., Ajazi, A., Pupa, S., Casola, S., Foiani, M., Mazzaferro, V., Pruneri, G., Milione, M. & de Braud, F., Apr 1 2019, In : International Journal of Cancer. 144, 7, p. 1704-1712 9 p.

Research output: Contribution to journalArticle

Neuroendocrine Tumors
Lipid Metabolism
Acetyl-CoA Carboxylase
Disease-Free Survival